Inhibitory effect of a caerulein-like peptide on human gastric secretion.
A synthetic heptapeptide corresponding to the C-terminal heptapeptide of caerulein but characterized by a nor-leucyl residue replacing the methyonyl residue of caerulein, when given by i.v. infusion (2 mug/kg/h), inhibited by 70-80% pentagastrin (4 mug/kg/h)-stimulated gastric secretion...
D000328:Adult; D002108:Ceruletide / Q000494:pharmacology*; D003864:Depression, Chemical; D004381:Duodenal Ulcer / Q000378:metabolism; D005750:Gastric Juice / Q000378:metabolism*; D006801:Humans; D010418:Pentagastrin / Q000494:pharmacology; D010443:Peptide Chain Termination, Translational; D010455:Peptides / Q000494:pharmacology*; D013997:Time Factors
D010455:Peptides; D002108:Ceruletide; D010418:Pentagastrin